US$ 26.13
glp 1 drugs and uti SGLT2i GLP-1 RA therapy in type diabetes and reno-vascular outcomes: a real-world study | Diabetologia Semaglutide and UTI: does GLP-1
Description
Were filing lawsuits against these drugmakers for failing to properly warn people of the risk of gastroparesis, ileus and intestinal blockages

For instance, in March 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, and for type 2 diabetes, it increased by 21%, while the percentage achieving target HbA1c levels rose to 37.9%
Quality-of-life assessments categorized outcomes as excellent, good, or poor: endoscopic group, 24 (73%), 5 (15%), 4 (12%)

Since these medications are not primarily processed by the kidneys, standard dosing schedules are generally appropriate for most CKD stages

Public Citizen

This could mean that we may see generics for popular drugs like semaglutide and tirzepatide in the future, further expanding treatment options for patients
